JOHNSON & JOHNSON
JNJ
DELAYED 1 MONTH
8 insider filings · Latest: Jun 9, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Sale | 4,075 | $247.87 | $1.0M | 23,682(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 11 8:56 PM | Eugene A. WoodsDirector | Grant/Award | 161.089 | — | 6,411.959(D) | View → |
| Jun 9, 2026 | Jun 11 8:43 PM | Daniel E PintoDirector | Grant/Award | 134.241 | — | 2,320.824(D) | View → |
| Jun 9, 2026 | Jun 11 8:35 PM | Marillyn A HewsonDirector | Grant/Award | 214.786 | — | 15,791.877(D) | View → |
| May 1, 2026 | May 4 8:58 PM | REED JOHN CEVP, Innovative Medicine, R&D | Option Exercise | 25,255 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 206.492 | — | 14,512.94(D) | View → |
| Mar 4, 2025 | Mar 13 1:31 AM | Marillyn A HewsonDirector | Grant/Award | 75.256 | — | 14,306.449(D) | View → |
| Mar 10, 2026 | Mar 13 12:39 AM | Daniel E PintoDirector | Grant/Award | 129.058 | — | 462.069(D) | View → |
| Mar 10, 2026 | Mar 13 12:37 AM | Eugene A. WoodsDirector | Grant/Award | 154.869 | — | 5,240.094(D) | View → |
| Feb 27, 2026 | Mar 3 9:21 PM | Robert J DeckerVP Corporate Controller | Option Exercise | 4,075 | $115.67 | 0(D) | View → |